Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer
Clinical trial NCT01152710 · COMPLETED
Trial details
- NCT number
- NCT01152710
- Sponsor
- Institute of Oncology Ljubljana
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2006-03-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.